Hypertonic acetate-ααhemoglobin for small volume resuscitation of hemorrhagic shock

L. F. Poli De Figueiredo, G. I. Elgjo, M. Mathru, M. Rocha E Silva, George Kramer

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hypertonic acetate solution in small volumes greatly improves cardiac output and corrects acid-base disturbances in hemorrhaged animals. We hypothesized that the combination of αα-crosslinked human hemoglobin (ααHb), an oxygen carrier and vasoconstrictor, with hypertonic sodium acetate (HAHb), a vasodilator, may be effective for small volume resuscitation of hemorrhagic shock. Six pigs hemorrhaged to a mean arterial pressure of 40 mmHg for 60 min (bled volume: 23.6 ± 2.5 ml·kg-1) received a single bolus of 4 ml·kg-1 of HAHb infused over two min. HAHb restored arterial pressure, increased systemic vascular resistance and caused a modest increase in cardiac output and SvO2, while pulmonary arterial pressure and vascular resistance were markedly increased. In two animals, transient severe hypotension and low cardiac output may have been due to acute pulmonary hypertension during injection. Compared to our previous study, in which animals received 4 ml·kg-1 of ααHb alone, HAHb produced higher cardiac output and a smaller increase in systemic and pulmonary vascular resistance. However, slower, titrated infusions may be needed when hemoglobin solutions are combined with drugs or solutions that cause vasodilatation in order to decrease the likelihood of acute hemodynamic instability.

Original languageEnglish (US)
Pages (from-to)61-73
Number of pages13
JournalArtificial Cells, Blood Substitutes, and Immobilization Biotechnology
Volume25
Issue number1-2
StatePublished - Jan 1997

Fingerprint

Resuscitation
Hemorrhagic Shock
Hemoglobin
Vascular Resistance
Hemoglobins
Animals
Acetates
Arterial Pressure
Cardiac Output
Sodium Acetate
High Cardiac Output
Hemodynamics
Vasoconstrictor Agents
Hypertonic Solutions
Vasodilator Agents
Low Cardiac Output
Sodium
Pulmonary Hypertension
Vasodilation
Hypotension

ASJC Scopus subject areas

  • Biomedical Engineering
  • Hematology
  • Biotechnology
  • Biomaterials

Cite this

Hypertonic acetate-ααhemoglobin for small volume resuscitation of hemorrhagic shock. / Poli De Figueiredo, L. F.; Elgjo, G. I.; Mathru, M.; Rocha E Silva, M.; Kramer, George.

In: Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, Vol. 25, No. 1-2, 01.1997, p. 61-73.

Research output: Contribution to journalArticle

Poli De Figueiredo, L. F. ; Elgjo, G. I. ; Mathru, M. ; Rocha E Silva, M. ; Kramer, George. / Hypertonic acetate-ααhemoglobin for small volume resuscitation of hemorrhagic shock. In: Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 1997 ; Vol. 25, No. 1-2. pp. 61-73.
@article{92376631b8d647c6a46be36161706536,
title = "Hypertonic acetate-ααhemoglobin for small volume resuscitation of hemorrhagic shock",
abstract = "Hypertonic acetate solution in small volumes greatly improves cardiac output and corrects acid-base disturbances in hemorrhaged animals. We hypothesized that the combination of αα-crosslinked human hemoglobin (ααHb), an oxygen carrier and vasoconstrictor, with hypertonic sodium acetate (HAHb), a vasodilator, may be effective for small volume resuscitation of hemorrhagic shock. Six pigs hemorrhaged to a mean arterial pressure of 40 mmHg for 60 min (bled volume: 23.6 ± 2.5 ml·kg-1) received a single bolus of 4 ml·kg-1 of HAHb infused over two min. HAHb restored arterial pressure, increased systemic vascular resistance and caused a modest increase in cardiac output and SvO2, while pulmonary arterial pressure and vascular resistance were markedly increased. In two animals, transient severe hypotension and low cardiac output may have been due to acute pulmonary hypertension during injection. Compared to our previous study, in which animals received 4 ml·kg-1 of ααHb alone, HAHb produced higher cardiac output and a smaller increase in systemic and pulmonary vascular resistance. However, slower, titrated infusions may be needed when hemoglobin solutions are combined with drugs or solutions that cause vasodilatation in order to decrease the likelihood of acute hemodynamic instability.",
author = "{Poli De Figueiredo}, {L. F.} and Elgjo, {G. I.} and M. Mathru and {Rocha E Silva}, M. and George Kramer",
year = "1997",
month = "1",
language = "English (US)",
volume = "25",
pages = "61--73",
journal = "Artificial Cells, Nanomedicine and Biotechnology",
issn = "2169-1401",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - Hypertonic acetate-ααhemoglobin for small volume resuscitation of hemorrhagic shock

AU - Poli De Figueiredo, L. F.

AU - Elgjo, G. I.

AU - Mathru, M.

AU - Rocha E Silva, M.

AU - Kramer, George

PY - 1997/1

Y1 - 1997/1

N2 - Hypertonic acetate solution in small volumes greatly improves cardiac output and corrects acid-base disturbances in hemorrhaged animals. We hypothesized that the combination of αα-crosslinked human hemoglobin (ααHb), an oxygen carrier and vasoconstrictor, with hypertonic sodium acetate (HAHb), a vasodilator, may be effective for small volume resuscitation of hemorrhagic shock. Six pigs hemorrhaged to a mean arterial pressure of 40 mmHg for 60 min (bled volume: 23.6 ± 2.5 ml·kg-1) received a single bolus of 4 ml·kg-1 of HAHb infused over two min. HAHb restored arterial pressure, increased systemic vascular resistance and caused a modest increase in cardiac output and SvO2, while pulmonary arterial pressure and vascular resistance were markedly increased. In two animals, transient severe hypotension and low cardiac output may have been due to acute pulmonary hypertension during injection. Compared to our previous study, in which animals received 4 ml·kg-1 of ααHb alone, HAHb produced higher cardiac output and a smaller increase in systemic and pulmonary vascular resistance. However, slower, titrated infusions may be needed when hemoglobin solutions are combined with drugs or solutions that cause vasodilatation in order to decrease the likelihood of acute hemodynamic instability.

AB - Hypertonic acetate solution in small volumes greatly improves cardiac output and corrects acid-base disturbances in hemorrhaged animals. We hypothesized that the combination of αα-crosslinked human hemoglobin (ααHb), an oxygen carrier and vasoconstrictor, with hypertonic sodium acetate (HAHb), a vasodilator, may be effective for small volume resuscitation of hemorrhagic shock. Six pigs hemorrhaged to a mean arterial pressure of 40 mmHg for 60 min (bled volume: 23.6 ± 2.5 ml·kg-1) received a single bolus of 4 ml·kg-1 of HAHb infused over two min. HAHb restored arterial pressure, increased systemic vascular resistance and caused a modest increase in cardiac output and SvO2, while pulmonary arterial pressure and vascular resistance were markedly increased. In two animals, transient severe hypotension and low cardiac output may have been due to acute pulmonary hypertension during injection. Compared to our previous study, in which animals received 4 ml·kg-1 of ααHb alone, HAHb produced higher cardiac output and a smaller increase in systemic and pulmonary vascular resistance. However, slower, titrated infusions may be needed when hemoglobin solutions are combined with drugs or solutions that cause vasodilatation in order to decrease the likelihood of acute hemodynamic instability.

UR - http://www.scopus.com/inward/record.url?scp=0030952961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030952961&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 61

EP - 73

JO - Artificial Cells, Nanomedicine and Biotechnology

JF - Artificial Cells, Nanomedicine and Biotechnology

SN - 2169-1401

IS - 1-2

ER -